Regulation of granuloma fibrosis by nitric oxide during Mycobacterium avium experimental infection

International Journal of Experimental Pathology

Volumn 87, Issue 4, 2006, Pages 307-315

  Lousada, Susana ^a   Flórido, Manuela ^a   Appelberg, Rui ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Cell mediated immunity; Fibrosis; Macrophages; Mycobacteria

Indexed keywords

COLLAGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; FIBROSIS; GRANULOMA; HISTOLOGY; IMAGE ANALYSIS; IMMUNOCOMPETENCE; INFECTION SENSITIVITY; LYMPHOID CELL; MOUSE; MOUSE STRAIN; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COLLAGEN; FIBROSIS; GRANULOMA; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 33745915521     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2006.00487.x     Document Type: Article

References (34)

1. Agostini C. & Semenzato G. (2003) Sarcoidosis. In: Granulomatous Infections and Inflammations: Cellular and Molecular Mechanisms. pp 265-292. (ed. D.L. Boros) Washington DC: ASM Press.
2. Benini J., Ehlers E.M., Ehlers S. (1999) Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium. J. Pathol. 189, 127-137.
3. Brunet L.R., Beall M., Dunne D.W., Pearce E.J. (1999) Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection. J. Immunol. 163, 4976-4984.
4. Doherty T.M. & Sher A. (1997) Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. J. Immunol. 158, 4822-4831.
5. Ehlers S., Kutsch S., Benini J. et al. (1999) NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology 98, 313-323.
6. Ehlers S., Kutsch S., Ehlers E.M., Benini J., Pfeffer K. (2000) Lethal granuloma disintegration in mycobacteria-infected TNFRp55-/-mice is dependent on T cells and IL-12. J. Immunol. 165, 483-492.
7. Facchetti F., Vermi W., Fiorentini S. et al. (1999) Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions. Am. J. Pathol. 154, 145-152.
8. Flórido M., Cooper A.M., Appelberg R. (2002) Immunological basis of the development of necrotic lesions following Mycobacterium avium infection. Immunology 106, 590-601.
9. Flórido M., Goncalves A.S., Silva R.A., Ehlers S., Cooper A.M., Appelberg R. (1999) Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis. Infect. Immun. 67, 3610-3618.
10. Flórido M., Pearl J.E., Solache A. et al. (2005) Gamma interferon-induced T-cell loss in virulent Mycobacterium avium infection. Infect. Immun. 73, 3577-3586.
11. Friedman S.L. (1993) The cellular basis of hepatic fibrosis-mechanisms and treatment strategies. N. Engl. J. Med. 328, 1828-1835.
12. Friedman S.L., Roll F.J., Boyles J., Bissell D.M. (1985) Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc. Natl. Acad. Sci. USA 82, 8681-8685.
13. Gomes M.S., Flórido M., Pais T.F., Appelberg R. (1999) Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J. Immunol. 162 (0), 6734-6739.
14. Hernandez-Pando R., Aguillar D., Hernandez M.L.G., Orozco H., Rook G. (2004) Pulmonary tuberculosis in BALB/c mice with non-functional IL-4 genes: changes in the inflammatory effects of TNF-α and in the regulation of fibrosis. Eur. J. Immunol. 34, 174-183.
15. Hesse M., Cheever A.W., Jankovic D., Wynn T.A. (2000) NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am. J. Pathol. 157, 945-955.
16. Hesse M., Modolell M., La Flamme A.C. et al. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of 1-arginine metabolism. J. Immunol. 167, 6533-6544.
17. Hogaboam C.M., Chensue S.W., Steinhauser M.L. et al. (1997) Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide. J. Immunol. 159, 5585-5593.
18. Hogaboam C.M., Gallinat C.S., Bone-Larson C. et al. (1998) Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition. Am. J. Pathol. 153, 1861-1872.
19. Kaye P.M. & Engwerda C.R. (2003) Murine leishmaniasis. In: Granulomatous Infections and Inflammations: Cellular and Molecular Mechanisms. pp. 117-146. (ed. D.L. Boros) Washington DC: ASM Press.
20. MacMicking J.D., Nathan C., Hom G. et al. (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641-650.
21. MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., Nathan C.F. (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94, 5243-5248.
22. Nascimento F.R., Calich V.L., Rodriguez D., Russo M. (2002) Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility. J. Immunol. 168, 4593-4600.
23. Pearce E.J. & MacDonald A.S. (2002) The immunobiology of schistosomiasis. Nat Rev. Immunol. 2, 499-511.
24. Phan S.H., Varani J., Smith D. (1985) Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis. J. Clin. Invest. 76, 241-247.
25. Reeves H.L. & Friedman S.L. (2002) Activation of hepatic stellate cells - a key issue in liver fibrosis. Front. Biosci. 7, d808-826.
26. Restrepo B.I., Alvarez J.I., Castano J.A. et al. (2001) Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect. Immun. 69, 4554-4560.
27. Saunders B.M. & Cooper A.M. (2000) Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol. Cell Biol. 78, 334-341.
28. Saunders B.M., Frank A.A., Orme I.M. (1999) Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis. Immunology 98, 324-328.
29. Schwander S.K. & Ellner J.J. (2003) Human tuberculosis. In: Granulomatous Infections and Inflammations: Cellular and Molecular Mechanisms. pp. 173-206. (ed. D.L. Boros) Washington DC: ASM Press.
30. Turner O.C., Basaraba R.J., Orme I.M. (2003) Granuloma formation in mouse and guinea pig models of experimental tuberculosis. In: Granulomatous Infections and Inflammations: Cellular and Molecular Mechanisms. pp. 65-84. (ed. D.L. Boros) Washington DC: ASM Press.
31. Wangoo A., Brown I.N., Marshall B.G., Cook H.T., Young D.B., Shaw R.J. (2000) Bacille Calmette-Guerin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma). Clin. Exp. Immunol. 119, 92-98.
32. Wangoo A., Sparer T., Brown I.N. et al. (2001) Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J. Immunol. 166, 3432-3439.
33. Wynn T.A. (2003) Murine Schistosomiasis. In: Granulomatous Infections and Inflammations Cellular and Molecular Mechanisms. pp. 147-172. (ed. D.L. Boros) Washington DC: ASM Press.
34. Wynn T.A. (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4, 583-594.